Items where authors include "Giovannoni, G."
Article
Chataway, J., Williams, T., Blackstone, J. et al. (135 more authors) (2025) Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet, 406 (10512). pp. 1611-1624. ISSN 0140-6736
Muraro, P.A. orcid.org/0000-0002-3822-1218, Mariottini, A. orcid.org/0000-0002-1869-7067, Greco, R. orcid.org/0000-0002-6117-5328 et al. (41 more authors) (2025) Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT. Nature Reviews Neurology, 21 (3). pp. 140-158. ISSN 1759-4758
Blackstone, J., Williams, T., Nicholas, J.M. et al. (59 more authors) (2024) Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK. BMJ Open, 14 (9). e086414. ISSN 2044-6055
John, N., Li, Y., De Angelis, F. et al. (49 more authors) (2024) Brain reserve and physical disability in secondary progressive multiple sclerosis. BMJ Neurology Open, 6 (2). e000670. ISSN 2632-6140
Brittain, G. orcid.org/0000-0002-9903-7203, Petrie, J. orcid.org/0000-0001-6150-6724, Duffy, K.E.M. et al. (25 more authors) (2024) Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ Open, 14 (2). e083582. ISSN 2044-6055
Giovannoni, G., Ford, H.L., Schmierer, K. et al. (12 more authors) (2024) MS care: integrating advanced therapies and holistic management. Frontiers in Neurology, 14. 1286122. ISSN 1664-2295
Brittain, G. orcid.org/0000-0002-9903-7203, Coles, A.J., Giovannoni, G. orcid.org/0000-0001-9995-1700 et al. (7 more authors) (2023) Autologous haematopoietic stem cell transplantation for immune-mediated neurological diseases: what, how, who and why? Practical Neurology, 23 (2). pp. 139-145. ISSN 1474-7758
Allen-Philbey, K., De Trane, S., Mao, Z. et al. (35 more authors) (2021) Subcutaneous cladribine to treat multiple sclerosis : experience in 208 patients. Therapeutic Advances in Neurological Disorders, 14. ISSN 1756-2864
Allen-Philbey, K., De Trane, S., Mao, Z. et al. (35 more authors) (2021) Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients. Therapeutic Advances in Neurological Disorders, 14. ISSN 1756-2856
Marshall, I., Thrippleton, M.J., Bastin, M.E. et al. (17 more authors) (2018) Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study. Journal of Neurology, 265 (8). pp. 1795-1802. ISSN 0340-5354
Up a level